ISRG vs NOW: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
Intuitive Surgical, Inc. Β· Healthcare
$399.52
+22.4% upside to fair value
Med Conviction Grade B High Quality
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
ISRG has more upside to fair value (+22.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG NOW
Current Price $399.52 $139.82
Fair Value Estimate $488.97 $162.50
Upside to Fair Value +22.4% +16.2%
Market Cap $141.1B $144.6B
Forward P/E β€” β€”
EV / EBITDA 30.7x 43.1x
Price / Sales 12.8x 9.8x
Price / FCF 44.0x 31.5x
Revenue Growth YoY +18.5% +24.0%
Gross Margin 66.7% 74.8%
Operating Margin 31.3% 11.4%
Return on Equity 17.8% 13.8%
Dividend Yield 0% 0%
FCF Yield 2.28% 3.17%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric ISRG NOW
Zone Low $366.73 $121.88
Zone High $415.62 $138.12
In Buy Zone? Yes No
← ISRG Research    NOW Research β†’    All Research